The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Erectile Dysfunction Market Research Report 2025
Synopsis
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global Erectile Dysfunction market was valued at US$ 4863.9 million in 2023 and is anticipated to reach US$ 8108.8 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Eli Lilly is one of the most important global key manufacturers of erectile dysfunction, holds a share of about 10%, other key players include Teva Pharma and Pfizer, etc. North America is the largest market, occupied for over 40 percent, followed by Europe. In terms of type, tadalafil type is the largest segment, with a share of over 50%, and in terms of sales channels, the hospital pharmacies segment holds a share of over 30 percent.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction.
Report Scope
The Erectile Dysfunction market size, estimations, and forecasts are provided in terms of sales volume (Million Pill) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global Erectile Dysfunction market was valued at US$ 4863.9 million in 2023 and is anticipated to reach US$ 8108.8 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Eli Lilly is one of the most important global key manufacturers of erectile dysfunction, holds a share of about 10%, other key players include Teva Pharma and Pfizer, etc. North America is the largest market, occupied for over 40 percent, followed by Europe. In terms of type, tadalafil type is the largest segment, with a share of over 50%, and in terms of sales channels, the hospital pharmacies segment holds a share of over 30 percent.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction.
Report Scope
The Erectile Dysfunction market size, estimations, and forecasts are provided in terms of sales volume (Million Pill) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Erectile Dysfunction Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction
1.2 Erectile Dysfunction Segment by Type
1.2.1 Global Erectile Dysfunction Market Value Comparison by Type (2024-2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Segment by Application
1.3.1 Global Erectile Dysfunction Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Revenue 2019-2030
1.4.2 Global Erectile Dysfunction Sales 2019-2030
1.4.3 Global Erectile Dysfunction Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Sales Market Share by Manufacturers (2019-2024)
2.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Erectile Dysfunction Average Price by Manufacturers (2019-2024)
2.4 Global Erectile Dysfunction Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction, Product Type & Application
2.7 Erectile Dysfunction Market Competitive Situation and Trends
2.7.1 Erectile Dysfunction Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Erectile Dysfunction Players Market Share by Revenue
2.7.3 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Erectile Dysfunction Retrospective Market Scenario by Region
3.1 Global Erectile Dysfunction Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Erectile Dysfunction Global Erectile Dysfunction Sales by Region: 2019-2030
3.2.1 Global Erectile Dysfunction Sales by Region: 2019-2024
3.2.2 Global Erectile Dysfunction Sales by Region: 2025-2030
3.3 Global Erectile Dysfunction Global Erectile Dysfunction Revenue by Region: 2019-2030
3.3.1 Global Erectile Dysfunction Revenue by Region: 2019-2024
3.3.2 Global Erectile Dysfunction Revenue by Region: 2025-2030
3.4 North America Erectile Dysfunction Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Erectile Dysfunction Sales by Country (2019-2030)
3.4.3 North America Erectile Dysfunction Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erectile Dysfunction Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Erectile Dysfunction Sales by Country (2019-2030)
3.5.3 Europe Erectile Dysfunction Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Market Facts & Figures by Country
3.6.1 Asia Pacific Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Erectile Dysfunction Sales by Country (2019-2030)
3.6.3 Asia Pacific Erectile Dysfunction Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Erectile Dysfunction Sales by Country (2019-2030)
3.7.3 Latin America Erectile Dysfunction Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Erectile Dysfunction Sales by Country (2019-2030)
3.8.3 Middle East and Africa Erectile Dysfunction Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Sales by Type (2019-2030)
4.1.1 Global Erectile Dysfunction Sales by Type (2019-2024)
4.1.2 Global Erectile Dysfunction Sales by Type (2025-2030)
4.1.3 Global Erectile Dysfunction Sales Market Share by Type (2019-2030)
4.2 Global Erectile Dysfunction Revenue by Type (2019-2030)
4.2.1 Global Erectile Dysfunction Revenue by Type (2019-2024)
4.2.2 Global Erectile Dysfunction Revenue by Type (2025-2030)
4.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2019-2030)
4.3 Global Erectile Dysfunction Price by Type (2019-2030)
5 Segment by Application
5.1 Global Erectile Dysfunction Sales by Application (2019-2030)
5.1.1 Global Erectile Dysfunction Sales by Application (2019-2024)
5.1.2 Global Erectile Dysfunction Sales by Application (2025-2030)
5.1.3 Global Erectile Dysfunction Sales Market Share by Application (2019-2030)
5.2 Global Erectile Dysfunction Revenue by Application (2019-2030)
5.2.1 Global Erectile Dysfunction Revenue by Application (2019-2024)
5.2.2 Global Erectile Dysfunction Revenue by Application (2025-2030)
5.2.3 Global Erectile Dysfunction Revenue Market Share by Application (2019-2030)
5.3 Global Erectile Dysfunction Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly Erectile Dysfunction Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Erectile Dysfunction Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Erectile Dysfunction Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Corporation Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Corporation Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.5.4 S.K. Chemicals Erectile Dysfunction Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Corporation Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharma Erectile Dysfunction Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dong-A ST Erectile Dysfunction Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Petros Pharmaceuticals
6.8.1 Petros Pharmaceuticals Corporation Information
6.8.2 Petros Pharmaceuticals Description and Business Overview
6.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Petros Pharmaceuticals Erectile Dysfunction Product Portfolio
6.8.5 Petros Pharmaceuticals Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Corporation Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Seoul Pharma Erectile Dysfunction Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 Yabang Pharmacy
6.10.1 Yabang Pharmacy Corporation Information
6.10.2 Yabang Pharmacy Description and Business Overview
6.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yabang Pharmacy Erectile Dysfunction Product Portfolio
6.10.5 Yabang Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Industry Chain Analysis
7.2 Erectile Dysfunction Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Production Mode & Process
7.4 Erectile Dysfunction Sales and Marketing
7.4.1 Erectile Dysfunction Sales Channels
7.4.2 Erectile Dysfunction Distributors
7.5 Erectile Dysfunction Customers
8 Erectile Dysfunction Market Dynamics
8.1 Erectile Dysfunction Industry Trends
8.2 Erectile Dysfunction Market Drivers
8.3 Erectile Dysfunction Market Challenges
8.4 Erectile Dysfunction Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
